This company says its gene-editing tech can create therapeutic cannabinoids and less harmful tobacco products

Growth op

The U.S Food and Drug Administration (FDA) has Big Tobacco in its crosshairs and one biotech company reports it can help reform the industry. Kentucky-based Demeetra AgBio, Inc., a genetic engineering company, has announced its proprietary gene-editing platform, Cas-CLOVER , could be used to produce less harmful tobacco products, as well as therapeutic cannabinoids. Israeli start-up claims it can make cannabis plants resistant to powdery mildew ‘I’m a firm believer that this is the next CBD’ Canadian researchers receive more than $4 million in funding to breed better cannabis At the end of April, the FDA announced it was “advancing two tobacco product standards to significantly reduce disease and death from using combusted tobacco products.” Those standards include a ban on menthol cigarettes, as well as a ban on all characterizing flavours, including menthol, in cigars. Canada implemented a federal ban on menthol in cigarettes , most cigars and blunt wraps in October 2017. “Banning menthol — the last allowable flavour — in cigarettes and banning all flavours in cigars will help save lives, particularly among those disproportionately affected by these deadly products,” said acting FDA commissioner Janet Woodcock . “With these actions, the FDA will help significantly reduce youth initiation, increase the chances of smoking cessation among current smokers and address health disparities experienced by communities of colour, low-income populations and LGBTQ+ individuals, all of whom are far more likely to use these tobacco products,” she added. For its part, Demeetra AgBio notes its platform, which is similar to the gene-editing technology CRISPR/Cas9, can be deployed in the tobacco and cannabis industries to create less harmful products. The technology is currently licensed to Demeetra AgBio and sister companies Hera BioLabs and Poseida Therapeutics , Deemetra AgBio CEO Jack Crawford recently told CRISPR Medicine News . And while CRISPR/Cas9 cannot be…

Excerpt only …
READ MORE BELOW
Source : This company says its gene-editing tech can create therapeutic cannabinoids and less harmful tobacco products

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.